Literature DB >> 19731306

Essential thrombocythemia and pregnancy: Observations from recent studies and management recommendations.

Ayalew Tefferi1, Francesco Passamonti.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19731306     DOI： 10.1002/ajh.21508

Source DB:  PubMed          Journal:  Am J Hematol        ISSN： 0361-8609            Impact factor:   10.047


× No keyword cloud information.
  7 in total

Review 1.  Special issues in myeloproliferative neoplasms.

Authors:  Tiziano Barbui; Guido Finazzi
Journal:  Curr Hematol Malig Rep       Date:  2011-03       Impact factor: 3.952

2.  Philadelphia-negative classical myeloproliferative neoplasms: critical concepts and management recommendations from European LeukemiaNet.

Authors:  Tiziano Barbui; Giovanni Barosi; Gunnar Birgegard; Francisco Cervantes; Guido Finazzi; Martin Griesshammer; Claire Harrison; Hans Carl Hasselbalch; Rudiger Hehlmann; Ronald Hoffman; Jean-Jacques Kiladjian; Nicolaus Kröger; Ruben Mesa; Mary F McMullin; Animesh Pardanani; Francesco Passamonti; Alessandro M Vannucchi; Andreas Reiter; Richard T Silver; Srdan Verstovsek; Ayalew Tefferi
Journal:  J Clin Oncol       Date:  2011-01-04       Impact factor: 44.544

3.  Pregnancy and myeloproliferative neoplasms : A retrospective monocentric cohort.

Authors:  Mathieu Puyade; Emilie Cayssials; Fabrice Pierre; Olivier Pourrat
Journal:  Obstet Med       Date:  2017-08-04

4.  Chronic myeloproliferative neoplasms: a collaborative approach.

Authors:  Lisa Pieri; Paola Guglielmelli; Alessandro M Vannucchi
Journal:  Mediterr J Hematol Infect Dis       Date:  2010-06-21       Impact factor: 2.576

Review 5.  Essential thrombocythemia treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

Review 6.  Polycythemia vera treatment algorithm 2018.

Authors:  Ayalew Tefferi; Alessandro M Vannucchi; Tiziano Barbui
Journal:  Blood Cancer J       Date:  2018-01-10       Impact factor: 11.037

Review 7.  Use of Interferon Alfa in the Treatment of Myeloproliferative Neoplasms: Perspectives and Review of the Literature.

Authors:  Joan How; Gabriela Hobbs
Journal:  Cancers (Basel)       Date:  2020-07-18       Impact factor: 6.639
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.